Laurus Labs Ltd. · NSE:LAURUSLABS

Laurus Labs — Merger or Acquisition (November 2020)

16 slides from Laurus Labs's merger presentation, Nov 25, 2020

  1. Slide 1: Cover letter to stock exchanges

    Laurus Labs Limited Corporate Office 2nd Floor. Serene Chambers. Road No. 7 Banjara Hills. Hyderabad- 50003~. Telangana, India T +91 ~0 6659 ~333, 3980 ~333, 23~2 0500 I 501 LAURUS Labs F +91 ~0 6659 ~320 I 3980 ~320 Knowledge . Innovation . Excellence November 25, 2020 To To The Corporate Relations

  2. Slide 2: Acquisition of Richcore Lifesciences Pvt. Ltd.

    LAURUS LABS LIMITED Acquisition of Richcore Lifesciences Pvt.Ltd. November 25, 2020 BSE: 540222 NSE : LAURUSLABS

  3. Slide 3: Disclaimer

    Disclaimer This presentation contains statements that constitute “forward looking statements” including and without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to our future business developments and economic performance. While these

  4. Slide 4: Agenda

    Agenda 1 Transaction Details 2 Strategic Rationale 3 Brief on Richcore 4 Synergy and Value Creation 5 Laurus Bio - Growth Trajectory 3

  5. Slide 5: Transaction in Brief

    Transaction in Brief  Laurus Labs has executed Definitive Agreement for acquisition of majority stake (72.55%) in Richcore Lifesciences Pvt Ltd (Richcore).  Richcore is being valued at Rs. 340 Cr and the cost of acquisition of 72.55% stake will be Rs. 246.7Cr and will be funded through internal ac

  6. Slide 6: Strategic Rationale

    Strategic Rationale Entry into high growth Diversification of Ability to scale segment revenue base operations Ability to become Increased demand for Enzyme Chemistry- vertically integrated fermentation capability Bio-catalysis biotech company 5

  7. Slide 7: Richcore.. An Emerging Biotech Company

    Richcore.. An Emerging Biotech Company 01 Fast Growing Research Driven Bio - Manufacturing Company Recombinant products - animal origin Richcore 02 free products for safer, viral free bio manufacturing Precision Fermentation capabilities - scale up 03 expertise and large scale manufacturing capabili

  8. Slide 8: Richcore.. Business Areas

    Richcore.. Business Areas 1 Biotech Ingredients 2 Enzymes (Biocatalysis, Health & Nutrition, Various Industrial Applications) 3 CDMO Contract Development and Manufacturing 7

  9. Slide 9: Applications

    Applications 1 Cell Culture Media, Vaccine, Insulin and other Supplements for Stem Biotech Ingredients biologics manufacturing Cell, Regenerative Food Industry medicines 2 Enzymes Pharma- Biocatalysis Health & Nutrition Industrial Enzymes 3 CDMO Therapeutic Proteins, Food Industry Contract Developme

  10. Slide 10: Current Products and Applications

    Current Products and Applications Vaccine Insulin Products Biopharma Cell Culture Cultured Meat Manufacturing Manufacturing Recombinant Trypsin Recombinant Human Albumin Recombinant Carboxypeptidase B Recombinant Transferrin Recombinant Thermolysin Recombinant IGF – LR3 Recombinant Collagenase Recom

  11. Slide 11: Manufacturing Facilities

    Manufacturing Facilities R1  Located in Bengaluru, India  Total fermentation capacity of 1750 lts – 2 reactors of 5000 lts and 3 reactors of 250 lts  In-house QC lab well equipped for chemical and microbial testing  EHS, ISO 9001:2015, Halal, Kosher certified R2  Located in Tumkur (80 kms from

  12. Slide 12: Synergy and Value Creation

    Synergy and Value Creation Deep technical 01 expertise in biotechnology Richcore Large fermentation 02 capacity 1 Bio Catalysis- lean and green 2 One stop shop for biotech 3 Large fermentation Laurus Bio API processes ingredients capabilities A vertically integrated biotech company Deep expertise in

  13. Slide 13: Laurus Bio… Growth Trajectory

    Laurus Bio… Growth Trajectory  Vertically integrated biotech company - MAB’s, biosimilars - Enzymes - CDMO  Add CDMO capacity  Augment product portfolio  Become ‘one stop shop’ for all the biotech ingredients  Strengthen Enzymes business Long Term  Dominant player in the CDMO space with deep p

  14. Slide 14: Conference Call

    Conference Call Conference call on November 26, 2020 at 11.00 AM IST Details of the conference call are as follows: Timing 11.000 am IST on November 26, 2020 Conference dial-in Universal Dial-In +91 22 6280 1148 / + 91 22 7115 8049 India Local access Number +91 7045671221 Available all over India Si

  15. Slide 15: Contact us

    Contact us About Laurus Labs Ltd. Laurus Labs is a leading research driven Pharmaceutical manufacturing Company in India. We have grown to become one of the leading manufacturers of API for Anti-Retroviral (ARV), Oncology, Cardiovascular, Anti-Diabetics, Anti-Asthma and Gastroenterology .We are thri

  16. Slide 16: Thank You

    Thank You 15 | PLaunusias

Laurus Labs — Merger or Acquisition (November 2020) on 6ix